Alzheimer's disease has long been thought to be irreversible, but new research using a mouse model offers hope.

Guest columnist Melissa Zapanta Shelton is executive director of the Alzheimer’s Association Cleveland and Greater East Ohio chapters. Currently, 55 million people are living with Alzheimer’s disease ...

As we age, neurocognitive disorders, including dementia and Alzheimer’s disease, can be particularly worrisome, impacting not just the individual but also their loved ones. Understanding the ...

The NHS is not ready for a new era of diagnosing and treating Alzheimer’s disease, nor is the UK “keeping pace with the science”, experts have warned. The Alzheimer’s landscape is set to be ...

The NHS will not be rolling out two new drugs that have been hailed as landmark treatments for Alzheimer's disease. Lecanemab and donanemab are the first drugs to slow the progress of the disease but ...

An international trial involving 1,000 volunteers will aim to detect biomarkers associated with the condition.

Menopause is linked to a loss of grey matter in regions involved with memory and emotion, study suggests.

People often worry they will get Alzheimer’s disease if their parents did. But engaging in a healthy lifestyle can outweigh ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing. Understanding the difference isn’t just helpful for clarity, it’s essential for ...

Alzheimer’s may be driven far more by genetics than previously thought, with one gene playing an outsized role. Researchers ...

As individuals with Alzheimer's disease (AD) move from the mild cognitive impairment stage to moderate and severe dementia, ...